14158 Results (Page 434 of 567)
All Market Research Reports
Romania Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Romania Lung Cancer Therapeutics Market will reach a value of $164 Mn from $86 Mn in 2022, growing at a CAGR of 8.4% during 2022-2030. The Lung Cancer Therapeutics Market in Romania is dominated by a few domestic pharmaceutical companies such as Adamed Group, Polpharma Group, and Gedeon Richter Polska. The Lung Cancer Therapeutics Market in Romania is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Romania lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
Poland Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Poland Lung Cancer Therapeutics Market will reach a value of $333 Mn from $173 Mn in 2022, growing at a CAGR of 8.6% during 2022-2030. The Lung Cancer Therapeutics Market in Poland is dominated by a few domestic pharmaceutical companies such as Adamed Group, Polpharma Group, and Gedeon Richter Polska. The Lung Cancer Therapeutics Market in Poland is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Poland lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
Philippines Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Philippines Lung Cancer Therapeutics Market will reach a value of $127 Mn from $66 Mn in 2022, growing at a CAGR of 8.6% during 2022-2030. The Lung Cancer Therapeutics Market in the Philippines is dominated by a few domestic pharmaceutical companies such as United Laboratories, Pfizer Philippines, and Roche Philippines. The Lung Cancer Therapeutics Market in the Philippines is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Philippines lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
Netherlands Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Netherlands Lung Cancer Therapeutics Market will reach a value of $155 Mn from $77 Mn in 2022, growing at a CAGR of 8.6% during 2022-2030. The Lung Cancer Therapeutics Market in the Netherlands is dominated by a few domestic pharmaceutical companies such as Cristal Therapeutics, ISA Pharmaceuticals, and Merus. The Lung Cancer Therapeutics Market in the Netherlands is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Netherlands lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
Kenya Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Kenya Lung Cancer Therapeutics Market will reach a value of $396 Mn from $194 Mn in 2022, growing at a CAGR of 9.3% during 2022-2030. The Lung Cancer Therapeutics Market in Kenya is dominated by a few domestic pharmaceutical companies such as Universal Corporation Limited, Cosmos Limited, and Avenue Healthcare. The Lung Cancer Therapeutics Market in Kenya is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Kenya lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.l
Japan Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Japan Lung Cancer Therapeutics Market will reach a value of $3.5 Bn from $1.8 Bn in 2022, growing at a CAGR of 8.6% during 2022-2030. The Lung Cancer Therapeutics Market in Japan is dominated by a few domestic pharmaceutical companies such as Chugai Pharmaceutical, Taiho Pharmaceutical, and Ono Pharmaceutical. The Lung Cancer Therapeutics Market in Japan is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Japanese lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
Italy Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Italy Lung Cancer Therapeutics Market will reach a value of $1286 Mn from $715 Mn in 2022, growing at a CAGR of 7.6% during 2022-2030. The Lung Cancer Therapeutics Market in Italy is dominated by a few domestic pharmaceutical companies such as Menarini, Chiesi, and MolMed. The Lung Cancer Therapeutics Market in Italy is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Italy lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
Indonesia Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Indonesia Lung Cancer Therapeutics Market will reach a value of $334 Mn from $179 Mn in 2022, growing at a CAGR of 8.1% during 2022-2030. The Lung Cancer Therapeutics Market in Indonesia is dominated by a few domestic pharmaceutical companies such as Dexa Medica, Kalbe Farma, and Phapros. The Lung Cancer Therapeutics Market in Indonesia is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Indonesia lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
India Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the India Lung Cancer Therapeutics Market will reach a value of $1259 Mn from $542 Mn in 2022, growing at a CAGR of 11.1% during 2022-2030. The Lung Cancer Therapeutics Market in India is dominated by a few domestic pharmaceutical companies such as Lupin, Cipla, and Biocon. The Lung Cancer Therapeutics Market in India is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Indian lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
France Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the France Lung Cancer Therapeutics Market will reach a value of $1420 Mn from $820 Mn in 2022, growing at a CAGR of 7.1% during 2022-2030. The Lung Cancer Therapeutics Market in France is dominated by a few domestic pharmaceutical companies such as Sanofi, Ipsen, and Innate Pharma. The Lung Cancer Therapeutics Market in France is segmented into different types of cancer and different therapy type. Some of the major factors affecting the France lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
Egypt Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Egypt Lung Cancer Therapeutics Market will reach a value of $174 Mn from $83 Mn in 2022, growing at a CAGR of 9.6% during 2022-2030. The Lung Cancer Therapeutics Market in Egypt is dominated by a few domestic pharmaceutical companies such as EIPICO, Pharco Pharmaceuticals, and El-Nasr Pharmaceutical Chemicals. The Lung Cancer Therapeutics Market in Egypt is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Egypt lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
China Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the China Lung Cancer Therapeutics Market will reach a value of $5 Bn from $2.4 Bn in 2022, growing at a CAGR of 9.6% during 2022-2030. The Lung Cancer Therapeutics Market in China is dominated by a few domestic pharmaceutical companies such as BeiGene, Jiangsu Hengrui Medicine, and Hutchison. The Lung Cancer Therapeutics Market in China is segmented into different types of cancer and different therapy type. Some of the major factors affecting the China lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
Tanzania Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the Tanzania liver disease therapeutics market will reach a value of $15 Mn from $9 Mn in 2022, growing at a CAGR of 6.6% during 2022-2030. The liver disease therapeutics in Tanzania is dominated by a few domestic pharmaceutical companies such as Africa Pharmaceutical Company, Dexa Medica, and Elys Chemical Industries. The liver disease therapeutics market in Tanzania is segmented into different types of disease and different therapy types. Some of the major factors affecting the market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
Belgium Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Belgium Lung Cancer Therapeutics Market will reach a value of $122 Mn from $66 Mn in 2022, growing at a CAGR of 8.1% during 2022-2030. The Lung Cancer Therapeutics Market in Belgium is dominated by a few domestic pharmaceutical companies such as Ion Beam Applications, Oncurious, and Oxurion. The Lung Cancer Therapeutics Market in Belgium is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Belgium lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
Poland Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the Poland liver disease therapeutics market will reach a value of $216 Mn from $134 Mn in 2022, growing at a CAGR of 6.2 % during 2022-2030. The liver disease therapeutics in Poland is dominated by a few domestic pharmaceutical companies such as Polpharma, Adamed, and Hasco-Lek. The liver disease therapeutics market in Poland is segmented into different types of disease and different therapy types. Some of the major factors affecting the market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
Nigeria Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the Nigeria liver disease therapeutics market will reach a value of $35 Mn from $21 Mn in 2022, growing at a CAGR of 6.7 % during 2022-2030. Liver disease therapeutics in Nigeria is dominated by a few domestic pharmaceutical companies such as May & Baker Nigeria, GSK Nigeria, and Swiss Pharma Nigeria. The market in Nigeria is segmented into different types of diseases and different therapy types. Some of the major factors affecting the market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
Netherlands Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the Netherlands liver disease therapeutics market will reach a value of $97 Mn from $60 Mn in 2022, growing at a CAGR of 6.2 % during 2022-2030. Liver disease therapeutics in the Netherlands is dominated by a few domestic pharmaceutical companies such as Astellas Pharma, Philips Healthcare, and Pharming Group. The liver disease therapeutics market in the Netherlands is segmented into different types of disease and different therapy types. Some of the major factors affecting the market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
UAE Oncology Therapeutics Market Analysis
By 2030, it is anticipated that the UAE Oncology Therapeutics Market will reach a value of $1.8 Bn from $0.91 Bn in 2022, growing at a CAGR of 9.4% during 2022-2030. The Oncology Therapeutics Market in UAE is dominated by a few domestic pharmaceutical companies such as Neopharma, Medpharma, and Julphar. The Oncology Therapeutics Market in UAE is segmented into different types of cancer and different therapy type. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for UAE Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.
Kenya Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the Kenya liver disease therapeutics market will reach a value of $27 Mn from $16 Mn in 2022, growing at a CAGR of 6.8% during 2022-2030. Liver disease therapeutics in Kenya is dominated by a few domestic pharmaceutical companies such as Medisel Kenya Limited, Universal Corporation, and Laborex Kenya. The liver disease therapeutics market in Kenya is segmented into different types of disease and different therapy types. Some of the major factors affecting the market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
Belgium Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the Belgium liver disease therapeutics market will reach a value of $79 Mn from $51 Mn in 2022, growing at a CAGR of 5.7 % during 2022-30. Liver disease therapeutics in Belgium is dominated by a few domestic pharmaceutical companies such as Ablynx, UCB Pharma, and Galapagos. The Liver Disease Therapeutics market in Belgium is segmented into different types of disease and different therapy types. Some of the major factors affecting the Belgium liver disease therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
Japan Oncology Therapeutics Market Analysis
By 2030, it is anticipated that the Japan Oncology Therapeutics Market will reach a value of $22.3 Bn from $11.2 Bn in 2022, growing at a CAGR of 8.9% during 2022-2030. The Oncology Therapeutics Market in Japan is dominated by a few domestic pharmaceutical companies such as Takeda Pharmaceutical, Daiichi Sankyo, and Astellas Pharma. The Oncology Therapeutics Market in Japan is segmented into different types of cancer and different therapy type. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for Japan Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.
Italy Oncology Therapeutics Market Analysis
By 2030, it is anticipated that the Italy Oncology Therapeutics Market will reach a value of $8 Bn from $4.3 Bn in 2022, growing at a CAGR of 7.9% during 2022-2030. The Oncology Therapeutics Market in Italy is dominated by a few domestic pharmaceutical companies such as Dompe, MolMed, and Menarini. The Oncology Therapeutics Market in Italy is segmented into different types of cancer and different therapy type. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for Italy Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.
Indonesia Oncology Therapeutics Market Analysis
By 2030, it is anticipated that the Indonesia Oncology Therapeutics Market will reach a value of $2.1 Bn from $1.1 Bn in 2022, growing at a CAGR of 8.4% during 2022-2030. The Oncology Therapeutics Market in Indonesia is dominated by a few domestic pharmaceutical companies such as Dexa Medica, Kalbe Farma, and Tempo Scan Pacific. The Oncology Therapeutics Market in Indonesia is segmented into different types of cancer and different therapy type. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for Indonesia Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.
Spain Cardiovascular Diseases Therapeutics Market Analysis
Spain's cardiovascular disease therapeutics market is expected to witness growth from $3.13 Bn in 2022 to $5.08 Bn in 2030 with a CAGR of 6.22% for the year 2022-2030. People in Spain are becoming more aware of cardiovascular diseases and their implications, therefore, leading to the development of new and inventive therapeutic options for the treatment of cardiovascular disease in Spain. The Spain cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by the end user. Pharmagenus, Ferrer, and Janssen Pharmaceuticals are the major players in the Spain cardiovascular disease therapeutics market.
Egypt Oncology Therapeutics Market Analysis
By 2030, it is anticipated that the Egypt Oncology Therapeutics Market will reach a value of $1.1 Bn from $0.51 Bn in 2022, growing at a CAGR of 9.9% during 2022-2030. The Oncology Therapeutics Market in Egypt is dominated by a few domestic pharmaceutical companies such as Pharco, EIPICO, and Amoun Pharmaceutical. The Oncology Therapeutics Market in Egypt is segmented into different types of cancer and different therapy type. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for Egypt Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.
